TRANSDERMAL DRUG DELIVERY SYSTEM: A REVIEW

Sushma Verma; Abhishek Ojha

doi:10.22270/ijmspr.v4i1.21

Authors

Sushma Verma Noida Institute of Engineering and Technology, Pharmacy Institute, 19, Knowledge Park-II, Greater Noida, Uttar Pradesh, 201306
Abhishek Ojha Noida Institute of Engineering and Technology, Pharmacy Institute, 19, Knowledge Park-II, Greater Noida, Uttar Pradesh, 201306

DOI:

https://doi.org/10.22270/ijmspr.v4i1.21

Keywords:

Skin Introduction, Types of skin, ransdermal drug delivery system, Evaluation

Abstract

Skin is considered as the largest organ of the body and it has many different functions. The skin functions occur in thermoregulation, protection, metabolic functions and sensation. The skin is divided into two main regions, the epidermis, and the dermis, one of each providing a distinct overall role function of the skin. The dermis is mainly attached to an underlying hypodermis, which is also called subcutaneous connective tissue, which generally stores adipose tissue and also recognized as the superficial fascia of gross anatomy. Basically it is composed of three layers. The outer-most layer is called the epidermis, which serves as a barrier and protects the body from any infection. The second layer is called the dermis and consists of connective tissues which cushion the body from stress and strain. Now a day's the transdermal drug delivery system is the most prominent method for the drug delivery. Transdermal drug delivery system is basically the topically administered drug which are generally in the form of patches for the controlled and pre-determined effects of drug. These devices allow the drug to be delivered through the skin barrier or the outer most layer of the skin. Polymers are called backbone for the transdermal drug delivery system

Author Biographies

Sushma Verma , Noida Institute of Engineering and Technology, Pharmacy Institute, 19, Knowledge Park-II, Greater Noida, Uttar Pradesh, 201306

Noida Institute of Engineering and Technology, Pharmacy Institute, 19, Knowledge Park-II, Greater Noida, Uttar Pradesh, 201306

Abhishek Ojha , Noida Institute of Engineering and Technology, Pharmacy Institute, 19, Knowledge Park-II, Greater Noida, Uttar Pradesh, 201306

Noida Institute of Engineering and Technology, Pharmacy Institute, 19, Knowledge Park-II, Greater Noida, Uttar Pradesh, 201306

References

Chien Y W (1987), “Novel Drug Delivery Systems”, 2nd Edition, Drugs and Pharmaceutical Sciences, Marcel Dekker, Inc.washington, DC, Vol. 50, pp. 281-299.

Finnin B C and Morgan T M (1999), “Transdermal Penetration”, J Pharm Sci., Vol. 88, No. 10, pp. 955-958.

Allen L V, Popovich N G and Ansel H C, (2005), Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems, 8th Edition, Lippincott Williams &Wilkins, pp. 298-315.

Barry B (2002), Transdermal Drug Delivery, in Ed: Aulton M E, Pharmaceutics: The Science of Dosage Form Design, Churchill Livingston, pp :499-533.

Enclyopedia of Polymer Science and Technology, Interscience Publishers, A division of John Wiley and sons. Inc., 1976, Vol. 12, pp. 139-168.

Barry B W (1987), “Mode of Action of Penetration Enhancers in Human Skin”, J Control. Release, Vol. 6, pp. 85-97.

Keith A D (1983), “Polymer Matrix Consideration for Transdermal Devices”, Drug Dev Ind., Vol. 9, pp. 605-621.

FitzGerald G A and Patrono C (2001), “The Coxibs, Selective Inhibitors of Cyclooxygenase-2”, N Engl J Med. Vol. 345, No. 6, pp. 433-442.

Aquil M, Ali A, Sultana Y, Najmi A K (2004), “Fabrication and Evaluation of Polymeric Films for Transdermal Delivery of Pinacidil: Pharmazie”, Vol. 59, pp. 631-635.

Arabi H, Hashemi SA, Ajdari N (2002), “Preparation of a Transdermal Delivery System and Effect of Membrane Type for Scopolamine Drug”, Iranian Polymer J., Vol. 11, No. 4, pp. 245- 249.

Hock S Tan, William R Pfister (1999), “Pressure-sensitive Adhesives for Transdermal Drug Delivery Systems”, PSTT, Vol. 2, pp. 60-69.

Qvist M H, Hoeck U, Kreilgaard B, Madson F and Frokjaer S (2002), “Release of Chemical Penetration Enhancers From Drug-In-Adhesive Transdermal Patches”, Int J Pharm., Vol. 231, pp. 253-263.

Arcangelo, Virginia P, Peterson, Andrew M (2005), “Pharmacotherapeutics for Advanced Practice”, Published by Lippincott Williams & Wilkins, p. 74.

Eseldin Keleb, Rakesh Kumar Sharma, Esmaeil B Mosa, Abd-alkadar Z aljahwi (2010), “Transdermal Drug Delivery System-Design and Evaluation”, Int. J. of Advances in Pharm. Sci., Vol. 1, pp. 201- 211.

Vyas S P and Khar R K (2002), “Controlled Drug Delivery: Concepts and Advances, Vallabh Prakashan”, 1st Edition, pp. 411-447.

Vanbever R, Langers G, Montmayeur S and Preat V (1998), “Transdermal Delivery of Fentanyl: Rapid onset of Analgesia using Skin Electroporation”, J Control Release, Vol. 50, Nos. 1-3, pp. 225- 235.

Aulton M E (2007), “Pharmaceutics: The Science of Dosage Form Design”, Second Edition, Part Four, Dosage Form Design and Manufacture, Chapter 33, “Transdermal Drug Delivery”, pp. 499-533.

Lec S T, Yac S H, Kim S W and Berner B (xxxx), “One Way Membrane for Transdermal Drug Delivery Systems / System Optimization”, Int. J. Pharm., Vol. 77, pp. 231-237.

Singh J, Tripathi K T and Sakia T R (1993), “Effect of Penetration Enhancers on the In Vitro Transport of Ephedrine Through Rate Skin and Human Epidermis From Matrix Based Transdermal Formulations”, Drug. Dev. Ind. Pharm., Vol. 19, pp. 1623-1628.

Shaila L, Pandey S and Udupa N (2006), “Design and Evaluation of Matrix Type Membrane Controlled Transdermal Drug Delivery System of Nicotin Suitable For Use in Smoking Cessation”, Indian. Journ. Pharm. Sci., Vol. 68, pp. 179-84